Current filters:


Popular Filters

7840 to 7864 of 8457 results

Novartis 2nd qtr 2011 sales rise of 27% beats forecasts, but currency takes toll


First of the global drug majors to report second-quarter 2011 financial results, Switzerland’s Novartis…


MSF slams drugmakers for shutting down HIV drug discount programs in mid-income countries


Several pharmaceutical companies have abandoned HIV drug discount programs in middle-income countries,…


Now Boehringer and Bristol-Myers in talks to join Medicines Patent Pool for HIV medicines


Following swiftly on its first deal with a pharmaceutical company, the Medicines Patent Pool, which was…

Anti-viralsBoehringer IngelheimBristol-Myers SquibbGlobalPatentsPharmaceutical

Nabi plunges as NicVAX flops in Ph III trial


US drug developer Nabi Biopharmaceuticals (Nasdaq: NABI) saw its shares nose-dive 70% to $1.76 in early…

GlaxoSmithKlineNabi BiopharmaceuticalsPharmaceuticalResearchVaccines

Roche acquires German cancer testing firm mtm laboratories for up to 190 million euros


Switzerland’s Roche (ROG: SIX), a global leader in cancer therapeutics and diagnostics, it has…

Mergers & Acquisitionsmtm laboratoriesPharmaceuticalRoche

Shire’s Lialda now OKed for ulcerative colitis maintenance of remission in the USA


The US Food and Drug Administration has approved Ireland-headquartered specialty drugmaker Shire’s…

Gastro-intestinalsLialdaNorth AmericaPharmaceuticalRegulationShire

UK MoH reports on value-based medicines pricing consulation


The UK Department of Health has reported on its consultation on value-based pricing for medicines, in…


Companies play vital role in doctor education and patient health, Australian ethics seminar told


Medical education provided or sponsored by pharmaceutical companies fosters knowledge of prescription…

Asia-PacificMarkets & MarketingPharmaceutical

Indian pharma potential impacted by sub-standard IP regime, says BMI


India's pharmaceutical market is failing to fulfil its potential. Positive attributes include a huge…

Asia-PacificMarkets & MarketingPatentsPharmaceutical

US Senators debut bipartisan bill to encourage states to use generic drugs In Medicaid program


In an effort to increase consumer flexibility and save taxpayer dollars, US Senators Scott Brown (Republican,…

GenericsHealthcareNorth AmericaPharmaceuticalPolitics

Vical to earn as much as $130 million from TransVax deal with Astellas


US drug developer Vical (Nasdaq: VICL) saw its share price leap 11.6% to $4.80 after it revealed that…

Astellas PharmaGlobalLicensingPharmaceuticalResearchTransVaxVaccinesVical

New study shows US Medicare Part D Rx drug costs see significant decline


The average costs for medicines frequently used by the USA’s Medicare Part D beneficiaries have…

HealthcareNorth AmericaPharmaceuticalPricing

Roche to file for approval of pertuzumab, which does well as combo in Ph III breast cancer trial


Swiss drug major Roche (ROG: SIX) says it plans to seek approval of its monoclonal antibody pertuzumab…


Par Pharma branded business faces setback, say Zacks analysts


US drugmaker Par Pharmaceuticals’ (NYSE: PRX) proprietary products division, Strativa Pharmaceuticals,…

FinancialGenericsOncologyPar PharmaceuticalsPharmaceuticalStrativa PharmaceuticalsZuplenz

Private health care market in Poland to be worth over $12 billion in 2013


The value of the private health care segment in Poland increased by about 4% year-on-year in 2010, to…


European Commission and Australia OK Bristol-Myers Yervoy and Novo Nordisk’s FlexTouch


Following a recent positive recommendation from the European Medicine Agency’s advisory panel, Bristol-Myers…

Bristol-Myers SquibbDiabetesEuropeFlexTouchNovo NordiskOncologyPharmaceuticalRegulationYervoy

German pharma counts cost of drug price controls, calls for review


The clamour against the recent drug pricing reforms in Germany has grown steadily louder. Last week Eli…


7840 to 7864 of 8457 results

Back to top